Back to GALE Stock Lookup
Pages: 1 2 »» Last Page

Galena Biopharma (GALE) – Press Releases

Aug 24, 2015 07:05 AM Galena Biopharma Announces Independent Data Safety Monitoring Committee Recommends Reduction of Cardiac Toxicity Monitoring for NeuVax(TM) PRESENT Trial
Aug 24, 2015 07:05 AM Galena Biopharma Announces Independent Data Safety Monitoring Committee Recommends Reduction of Cardiac Toxicity Monitoring for NeuVax(TM) PRESENT Trial
Aug 6, 2015 04:10 PM Galena Biopharma Reports Second Quarter 2015 Financial Results
Aug 6, 2015 04:10 PM Galena Biopharma Reports Second Quarter 2015 Financial Results
Aug 5, 2015 10:03 AM MonoSol Rx Partner Galena Biopharma Launches Zuplenz(R) (Ondanestron) Oral Soluble Film
Jul 29, 2015 07:05 AM Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
Jul 29, 2015 07:05 AM Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
Jul 28, 2015 07:05 AM Galena Biopharma to Report Second Quarter Financial Results on Thursday, August 6, 2015
Jul 28, 2015 07:05 AM Galena Biopharma to Report Second Quarter Financial Results on Thursday, August 6, 2015
Jul 9, 2015 10:00 AM Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
Jun 15, 2015 07:05 AM Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Phase 2 Data at the European Hematology Association 20th Congress
Jun 15, 2015 07:05 AM Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Phase 2 Data at the European Hematology Association 20th Congress
May 28, 2015 04:10 PM Galena Biopharma to Present at the Sachs Immuno-Oncology BD&L and Investment Forum
May 28, 2015 04:10 PM Galena Biopharma to Present at the Sachs Immuno-Oncology BD&L and Investment Forum
May 27, 2015 07:05 AM Galena Biopharma Announces Publication of Two Abstracts at the 2015 American Society of Clinical Oncology Annual Meeting
May 27, 2015 07:05 AM Galena Biopharma Announces Publication of Two Abstracts at the 2015 American Society of Clinical Oncology Annual Meeting
May 22, 2015 07:05 AM Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial Data at the European Hematology Association 20th Congress
May 22, 2015 07:05 AM Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial Data at the European Hematology Association 20th Congress
May 7, 2015 04:15 PM Galena Biopharma Reports First Quarter 2015 Financial Results
May 7, 2015 04:15 PM Galena Biopharma Reports First Quarter 2015 Financial Results
Apr 23, 2015 07:05 AM Galena Biopharma to Report First Quarter Financial Results on Thursday, May 7, 2015
Apr 23, 2015 07:05 AM Galena Biopharma to Report First Quarter Financial Results on Thursday, May 7, 2015
Apr 14, 2015 07:21 AM Galena Biopharma Completes Over-Enrollment of NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
Apr 14, 2015 07:21 AM Galena Biopharma Completes Over-Enrollment of NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
Apr 10, 2015 11:15 AM Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $43.7 Million
Mar 31, 2015 07:05 AM Galena Biopharma to Present at the 14th Annual Needham Healthcare Conference
Mar 31, 2015 07:05 AM Galena Biopharma to Present at the 14th Annual Needham Healthcare Conference
Mar 26, 2015 07:05 AM Galena Biopharma Expands Patient Population in NeuVax(TM) (nelipepimut-S) and trastuzumab Phase 2b Combination Clinical Trial in HER2 1+/2+ Patients
Mar 26, 2015 07:05 AM Galena Biopharma Expands Patient Population in NeuVax(TM) (nelipepimut-S) and trastuzumab Phase 2b Combination Clinical Trial in HER2 1+/2+ Patients
Mar 18, 2015 04:35 PM Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants
Mar 18, 2015 04:35 PM Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants
Mar 13, 2015 09:22 AM Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
Mar 13, 2015 09:22 AM Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
Mar 12, 2015 04:01 PM Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants
Mar 12, 2015 04:01 PM Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants
Mar 3, 2015 07:05 AM Galena Biopharma to Present at the 27th Annual ROTH Conference
Feb 19, 2015 07:05 AM Galena Biopharma to Report Fourth Quarter and Year End 2014 Financial Results on Thursday, March 5, 2015
Feb 9, 2015 07:05 AM Galena Biopharma Enrolls 700th Patient in NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
Feb 5, 2015 07:05 AM Galena Biopharma Announces Orexo's Filing of a Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) Sublingual Tablets in the U.S.
Jan 28, 2015 07:05 AM Galena Biopharma to Present at the 17th Annual BIO CEO & Investor Conference
Jan 20, 2015 07:05 AM Galena Biopharma Hires Joseph Lasaga as Vice President, Business Development and Alliance Management
Jan 15, 2015 07:05 AM Galena Biopharma to Present at the Noble Financial Capital Markets 11th Annual Investor Conference
Dec 8, 2014 07:05 AM Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 5, 2014 07:05 AM Galena Biopharma to Present HER2 Screening Data From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)
Dec 2, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of U.S. Patent Application for GALE-401 (Anagrelide Controlled Release) Composition of Matter
Dec 1, 2014 07:05 AM Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 1 Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Nov 25, 2014 07:05 AM Galena Biopharma to Present at the Oppenheimer 25th Annual Healthcare Conference
Nov 20, 2014 04:20 PM Galena Biopharma Announces Purchase Agreement for Up to $55.0 Million With Lincoln Park Capital Fund, LLC
Nov 18, 2014 07:05 AM Galena Biopharma Completes Enrollment in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
Nov 13, 2014 07:05 AM Galena Biopharma to Present at the Stifel 2014 Healthcare Conference
Pages: 1 2 »» Last Page

Back to GALE Stock Lookup